Director of Marketing and Communications
Cancer Moonshot Blue Ribbon Panel Unveils Recommendations to the National Cancer Advisory Board
Bonnie J. Addario Foundation Congratulates Vice President Biden and the Blue Ribbon Panel for their Work to Accelerate Cancer Research
SAN CARLOS, Calif. (September 12, 2016) — This week, the Cancer Moonshot Blue Ribbon Panel, comprised of leaders from science, research and patient advocacy, presented their top 10 recommendations to the National Cancer Advisory Board.
The recommendations aim at the Moonshot goal of making 10 years of progress in five years. The 10 recommendations are:
As a patient founded and patient focused organization the Bonnie J. Addario Lung Cancer Foundation (ALCF) is excited about the recommendations, particularly the ones centered on using patients and patient data to accelerate research. “This is such a great time for cancer research, and as a survivor and patient advocate I am thrilled that Vice President Biden, Greg Simon and the Blue Ribbon Panel understand the importance of the patient being part of the solution,” said Bonnie J. Addario, 10-year lung cancer survivor and founder of the ALCF.
ALCF is grateful to Vice President Biden for continuing to push the efforts of the Cancer Moonshot and remaining focused and dedicated to giving cancer patients and survivors hope for the future. We look forward to working with the vice president and the Blue Ribbon Panel in the years to come. To view the Blue Ribbon Panel’s report and recommendations in full, please visit: www.cancer.gov/brp.
About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation’s goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised nearly $30 million for lung cancer research and related programs. For more information about the ALCF please visit www.lungcancerfoundation.org or follow us on Facebook or Twitter.